Inspire Medical Systems, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Inspire Medical Systems, Inc. payments for repurchase of common stock for the quarter ending 2026-06-30 was $0.00.
- Inspire Medical Systems, Inc. payments for repurchase of common stock for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Inspire Medical Systems, Inc. payments for repurchase of common stock for the quarter ending 2025-12-31 was $50.01M.
- Inspire Medical Systems, Inc. payments for repurchase of common stock for the quarter ending 2025-09-30 was $50.00M.
- Inspire Medical Systems, Inc. payments for repurchase of common stock for fiscal 2025 was $175.02M.
- Inspire Medical Systems, Inc. payments for repurchase of common stock for fiscal 2024 was $0.00.
- Inspire Medical Systems, Inc. payments for repurchase of common stock for fiscal 2023 was $0.00.
- Inspire Medical Systems, Inc. payments for repurchase of common stock for fiscal 2022 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $100.01M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-04 | $100.01M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $50.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $175.02M 10-K · filed 2026-02-13 |
| 2025-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $125.01M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $75.01M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $75.01M 10-Q · filed 2026-05-04 | $75.01M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 10-K · filed 2026-02-13 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-05 | |
| 2023-12-31 | $0.00 10-K · filed 2026-02-13 | |
| 2022-12-31 | $0.00 10-K · filed 2025-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |